CIK 0001819411 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Gain Therapeutics, Inc.
Sign in to watch- Ticker
- GANX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851726310
- Phone
- (301) 500-1556
- Business address
- 4800 HAMPDEN LANE, SUITE 200, BETHESDA, MD, 20814
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-04-10 | Ballantyne Charles Evan Chief Financial Officer | Grant or award · Restricted Stock Units | +50,000 | 50,000 | ||
| 2023-03-23 | Calabrese Salvatore Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2023-03-23 | Calabrese Salvatore Chief Financial Officer | Grant or award · Restricted Stock Units | +25,000 | 25,000 | ||
| 2023-03-23 | Fuggetta Gianluca Principal Accounting Officer | Grant or award · Employee Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2023-03-23 | Alder Matthias Chief Executive Officer | Grant or award · Employee Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2023-03-23 | Alder Matthias Chief Executive Officer | Grant or award · Restricted Stock Units | +75,000 | 75,000 | ||
| 2022-09-20 | RICHMAN ERIC I Director | Grant or award · Employee Stock Option (right to buy) | +329,400 | 329,400 | ||
| 2022-09-20 | RICHMAN ERIC I Director | Grant or award · Restricted Stock Units | +54,900 | 54,900 | ||
| 2022-09-20 | Islam Khalid Director | Grant or award · Stock Option (right to buy) | +10,500 | 10,500 | ||
| 2022-09-20 | Riley Jeffrey Scott Director | Grant or award · Stock Option (right to buy) | +10,500 | 10,500 | ||
| 2022-09-20 | GOLDSTEIN DOV A MD Director | Grant or award · Stock Option (right to buy) | +10,500 | 10,500 | ||
| 2022-09-20 | Melincoff Gwen A Director | Grant or award · Stock Option (right to buy) | +10,500 | 10,500 | ||
| 2022-09-20 | Nicaise Claude Director | Grant or award · Stock Option (right to buy) | +10,500 | 10,500 | ||
| 2022-09-20 | HASLER HANS PETER Director | Grant or award · Stock Option (right to buy) | +10,500 | 10,500 | ||
| 2022-09-20 | Alder Matthias Chief Operating Officer | Grant or award · Employee Stock Option (right to buy) | +60,900 | 60,900 | ||
| 2022-09-20 | Alder Matthias Chief Operating Officer | Grant or award · Restricted Stock Units | +10,200 | 10,200 | ||
| 2022-07-15 | Calabrese Salvatore Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +59,400 | 59,400 | ||
| 2022-07-15 | Calabrese Salvatore Chief Financial Officer | Grant or award · Restricted Stock Units | +9,900 | 9,900 | ||
| 2022-07-15 | Alder Matthias Chief Operating Officer | Grant or award · Employee Stock Option (right to buy) | +79,200 | 79,200 | ||
| 2022-07-15 | Alder Matthias Chief Operating Officer | Grant or award · Restricted Stock Units | +13,200 | 13,200 |
Page 4 of 5 · 88 trades